Abstract
Aripiprazole contributes an increase in body mass index and attenuation in anorexia nervosa (AN) symptoms, leading clinical improvements with lower side-effect profile; but it is not enough to cure comorbid depressive symptoms in AN.
Author supplied keywords
Cite
CITATION STYLE
APA
Tahıllıoğlu, A., Özcan, T., Yüksel, G., Majroh, N., Köse, S., & Özbaran, B. (2020). Is aripiprazole a key to unlock anorexia nervosa?: A case series. Clinical Case Reports, 8(12), 2827–2834. https://doi.org/10.1002/ccr3.3271
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free